Vertex Pharmaceuticals Incorporated logo VRTX - Vertex Pharmaceuticals Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 48
HOLD 8
SELL 0
STRONG
SELL 0
| PRICE TARGET: $552.80 DETAILS
HIGH: $616.00
LOW: $436.00
MEDIAN: $558.00
CONSENSUS: $552.80
UPSIDE: 27.22%

Profitability Ratios

Ratio Value
GP Margin 85.0%
EBIT Margin 39.4%
EBITDA Margin 41.1%
Operating Margin 39.4%
Pretax Margin 38.5%
Cont. Ops Margin 32.7%
Net Margin 32.7%
Bottom Line Margin 32.7%

Liquidity Ratios

Ratio Value
Current Ratio 2.90
Quick Ratio 2.46
Solvency Ratio 0.556
Cash Ratio 1.32

Valuation Ratios

Ratio Value
Price/Earnings
29.32
Hist. avg: 42.1
Peers avg: 34.7
PEG Ratio -0.03
Forward PEG -0.03
Price/Book 6.21
Price/Sales 9.60
Price/FCF 36.30
Price/Op Cash Flow 31.92

Debt Ratios

Ratio Value
Debt/Assets 0.1485
Debt/Equity 0.2080
Debt/Capital 0.1722
Long-Term Debt/Capital 0.0900
Financial Leverage 1.40

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.81
Operating Cash Flow Ratio 0.940
Operating Cash Flow/Sales 30.1%
Free Cash Flow/Operating Cash Flow 87.9%

Coverage Ratios

Ratio Value
Debt Service Coverage 44.52
Interest Coverage 357.9474
Short-Term Operating Cash Flow Coverage 43.86
Operating Cash Flow Coverage 0.94
Capital Expenditure Coverage 8.30
Dividend + Capital Expenditure Coverage 8.30

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 47.22
EPS 15.460
Debt/Share 15.2358
Cash/Share 25.85
Book Value/Share 73.00
Tangible BV/Share 67.08
Equity/Share 73.00
Operating Cash Flow/Share 14.202
Capital Expenditure/Share 1.711
FCF/Share 12.490

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.851
Earnings Before Tax/EBIT 0.975
Price/Fair Value 6.21
Debt/Market Cap 0.0166
Effective Tax Rate 14.9%
Enterprise Value Multiple 23.09